NucMed Publications

Accepted or to appear

  1. M.A.H. Berrevoets, I.J.E. Kouijzer, E.H.J.G. Aarntzen, M.J.R. Janssen, L.-F. De Geus-Oei, H.F.L. Wertheim, B.-J. Kullberg, J. Ten Oever, W.J.G. Oyen and C.P. Bleeker-Rovers. "(18)F-FDG-PET/CT optimizes treatment in Staphylococcus aureus bacteremia and is associated with reduced mortality.", Journal of nuclear medicine : official publication, Society of Nuclear Medicine. Abstract DOI PMID 28336786

  2. I. van der Kroon, W. Woliner-van der Weg, M. Brom, L. Joosten, C. Frielink, M.W. Konijnenberg, E.P. Visser and M. Gotthardt. "Whole organ and islet of Langerhans dosimetry for calculation of absorbed doses resulting from imaging with radiolabeled exendin.", Scientific reports;7:39800. Abstract DOI PMID 28067253

  3. R.A. Nadar, N. Margiotta, M. Iafisco, J.J.J.P. van den Beucken, O.C. Boerman and S.C.G. Leeuwenburgh. "Bisphosphonate-Functionalized Imaging Agents, Anti-Tumor Agents and Nanocarriers for Treatment of Bone Cancer.", Advanced healthcare materials. Abstract DOI PMID 28207199


  1. E.H.J.G. Aarntzen, L. Heijmen and W.J.G. Oyen. "18F-FDG PET/CT in Local Ablative Therapies: A Systematic Review", Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2018;59:551-556. Abstract DOI PMID 29348320

  2. S. Carvalho, R.T.H. Leijenaar, E.G.C. Troost, J.E. van Timmeren, C. Oberije, W. van Elmpt, L.-F. de Geus-Oei, J. Bussink and P. Lambin. "18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study", PloS one 2018;13:e0192859. Abstract DOI PMID 29494598

  3. V. Christmann, M.E. van der Putten, L. Rodwell, K. Steiner, M. Gotthardt, J.B. van Goudoever and A.F.J. van Heijst. "Effect of early nutritional intake on long-term growth and bone mineralization of former very low birth weight infants.", Bone 2018;108:89-97. Abstract DOI PMID 29289790

  4. S. Demine, A. Balhuizen, V. Debaille, L. Joosten, M. Fereau, S.N.M. Chilla, I. Millard, R. Scharfmann, D. Egrise, S. Goldman, P. Marchetti, M. Gotthardt, S. Laurent, C. Burtea and D.L. Eizirik. "Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2γa.", Molecules (Basel, Switzerland) 2018;23. Abstract DOI PMID 30134599

  5. D. Evers, B.M.A.M. Bär, M. Gotthardt and W.J.F.M. van der Velden. "Activity of decitabine in pericardial myeloid sarcoma.", International journal of hematology 2018;108:121-122. DOI PMID 29779081

  6. S. Fanti, S. Minozzi, G. Antoch, I. Banks, A. Briganti, I. Carrio, A. Chiti, N. Clarke, M. Eiber, J. De Bono, K. Fizazi, S. Gillessen, S. Gledhill, U. Haberkorn, K. Herrmann, R.J. Hicks, F. Lecouvet, R. Montironi, P. Ost, J.M. O'Sullivan, A.R. Padhani, J.A. Schalken, H.I. Scher, B. Tombal, R.J.A. van Moorselaar, H. Van Poppel, H.A. Vargas, J. Walz, W.A. Weber, H.-J. Wester and W.J.G. Oyen. "Consensus on molecular imaging and theranostics in prostate cancer.", The Lancet. Oncology 2018;19:e696-e708. Abstract DOI PMID 30507436

  7. T. van der Geest, D.M. Roeleveld, B. Walgreen, M.M. Helsen, T.K. Nayak, C. Klein, M. Hegen, G. Storm, J.M. Metselaar, W.B. van den Berg, P.M. van der Kraan, P. Laverman, O.C. Boerman and M.I. Koenders. "Imaging fibroblast activation protein to monitor therapeutic effects of neutralizing interleukin-22 in collagen-induced arthritis.", Rheumatology (Oxford, England) 2018;57:737-747. Abstract DOI PMID 29361119

  8. M. Gotthardt, D.L. Eizirik, H.-J. Aanstoot, O. Korsgren, D. Mul, F. Martin, M. Boss, T.J.P. Jansen, S.A.M. van Lith, M. Buitinga, O. Eriksson, M. Cnop and M. Brom. "Detection and quantification of beta cells by PET imaging: why clinical implementation has never been closer.", Diabetologia 2018;61:2516-2519. Abstract DOI PMID 30284016

  9. W. Grootjans, L.-F. de Geus-Oei and J. Bussink. "Image-guided adaptive radiotherapy in patients with locally advanced non-small cell lung cancer: the art of PET.", The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 2018;62:369-384. Abstract DOI PMID 29869486

  10. M.C. Hekman, M. Rijpkema, C.H. Muselaers, E. Oosterwijk, C.A. Hulsbergen-Van de Kaa, O.C. Boerman, W.J. Oyen, J.F. Langenhuijsen and P.F. Mulders. "Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study.", Theranostics 2018;8:2161-2170. Abstract DOI PMID 29721070

  11. M.C.H. Hekman, M. Rijpkema, E.H. Aarntzen, S.F. Mulder, J.F. Langenhuijsen, E. Oosterwijk, O.C. Boerman, W.J.G. Oyen and P.F.A. Mulders. "Positron Emission Tomography/Computed Tomography with , javax.xml.bind.JAXBElement@51511e9, Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion.", European urology 2018;74:257-260. Abstract DOI PMID 29730017

  12. L. Joosten, M. Brom, H. Peeters, S. Heskamp, M. Béhé, O. Boerman and M. Gotthardt. "Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging.", Molecular pharmaceutics 2018;15:486-494. Abstract DOI PMID 29226686

  13. E.J. de Koster, L.-F. de Geus-Oei, O.M. Dekkers, I. van Engen-van Grunsven, J. Hamming, E.P.M. Corssmit, H. Morreau, A. Schepers, J. Smit, W.J.G. Oyen and D. Vriens. "Diagnostic Utility of Molecular and Imaging Biomarkers in Cytological Indeterminate Thyroid Nodules.", Endocrine reviews 2018;39:154-191. Abstract DOI PMID 29300866

  14. I.J.E. Kouijzer, M.A.H. Berrevoets, E.H.J.G. Aarntzen, J. de Vries, A.P.J. van Dijk, W.J.G. Oyen, L.-F. de Geus-Oei and C.P. Bleeker-Rovers. "18F-fluorodeoxyglucose positron-emission tomography combined with computed tomography as a diagnostic tool in native valve endocarditis", Nuclear medicine communications 2018;39:747-752. Abstract DOI PMID 29762262

  15. I.J.E. Kouijzer, J.W.M. van der Meer, W.J.G. Oyen and C.P. Bleeker-Rovers. "Diagnostic yield of FDG-PET/CT in fever of unknown origin: a systematic review, meta-analysis, and Delphi exercise.", Clinical radiology 2018;73:588-589. DOI PMID 29567271

  16. I.J.E. Kouijzer, W.J.G. Oyen and C.P. Bleeker-Rovers. "Vascular infection with outside-in vertebral destruction in chronic Q fever.", The Lancet. Infectious diseases 2018;18:603. DOI PMID 29856356

  17. I.J.E. Kouijzer, H. Scheper, J.W.J. de Rooy, J.L. Bloem, M.J.R. Janssen, L. van den Hoven, A.J.F. Hosman, L.G. Visser, W.J.G. Oyen, C.P. Bleeker-Rovers and L.-F. de Geus-Oei. "The diagnostic value of , javax.xml.bind.JAXBElement@2ea3f20, F-FDG-PET/CT and MRI in suspected vertebral osteomyelitis - a prospective study.", European journal of nuclear medicine and molecular imaging 2018;45:798-805. Abstract DOI PMID 29256136

  18. C.M.T. Lageweg, M.E. van der Putten, J.B. van Goudoever, T. Feuth, M. Gotthardt, A.F.J. van Heijst and V. Christmann. "Evaluation of bone mineralization in former preterm born children: Phalangeal quantitative ultrasound cannot replace dual-energy X-ray absorptiometry.", Bone reports 2018;8:38-45. Abstract DOI PMID 29955621

  19. M.A. Lantinga, R.G.L. de Sévaux, T.J.G. Gevers, W.J.G. Oyen, J.W. de Fijter, D. Soonawala, R. Zietse, M. Salih, N.F. Casteleijn, E.M. Spithoven, E. Meijer, R.T. Gansevoort and J.P.H. Drenth On Behalf Of The Dipak Consortium. "Clinical predictors of escalating care in hepatic and renal cyst infection in autosomal dominant polycystic kidney and liver disease.", The Netherlands journal of medicine 2018;76:226-234. Abstract PMID 30019678

  20. S.T. Laurens, F. Witjes, M. Janssen, U. Flucke and M. Gottardt. "68Ga-Prostate-Specific Membrane Antigen Uptake in Gastrointestinal Stromal Tumor.", Clinical nuclear medicine 2018;43:60-61. Abstract DOI PMID 29166327

  21. Y. Liu, C. Schouten, O. Boerman, G. Wu, J.A. Jansen and E.B. Hunziker. "The kinetics and mechanism of bone morphogenetic protein 2 release from calcium phosphate-based implant-coatings.", Journal of biomedical materials research. Part A 2018;106:2363-2371. Abstract DOI PMID 29569828

  22. D. Lobeek, G.M. Franssen, M.T. Ma, H.-J. Wester, C. Decristoforo, W.J.G. Oyen, O.C. Boerman, S.Y.A. Terry and M. Rijpkema. "In Vivo Characterization of 4 , javax.xml.bind.JAXBElement@27b763e, Ga-Labeled Multimeric RGD Peptides to Image α, javax.xml.bind.JAXBElement@50cab567, β, javax.xml.bind.JAXBElement@bfd9634, Integrin Expression in 2 Human Tumor Xenograft Mouse Models.", Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2018;59:1296-1301. Abstract DOI PMID 29626124

  23. S. Lütje, D. Gerrits, J.D. Molkenboer-Kuenen, K. Herrmann, G. Fracasso, M. Colombatti, O.C. Boerman and S. Heskamp. "Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors.", Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2018;59:494-501. Abstract DOI PMID 29146698

  24. J. Napp, M.A. Stammes, J. Claussen, H.A.J.M. Prevoo, C.F.M. Sier, F.J.M. Hoeben, M.S. Robillard, A.L. Vahrmeijer, T. Devling, A.B. Chan, L.-F. de Geus-Oei and F. Alves. "Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.", International journal of cancer 2018;142:2118-2129. Abstract DOI PMID 29277891

  25. J. Odenthal, M. Rijpkema, D. Bos, E. Wagena, H. Croes, R. Grenman, O. Boerman, R. Takes and P. Friedl. "Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma.", Scientific reports 2018;8:10467. Abstract DOI PMID 29992954

  26. S.M.A. Willekens, L. Joosten, O.C. Boerman, M. Brom and M. Gotthardt. "Characterization of , javax.xml.bind.JAXBElement@5e6ff189, In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors.", Scientific reports 2018;8:2948. Abstract DOI PMID 29440684


  1. L.T. van der Meer, S.Y.A. Terry, D. van Ingen Schenau, K.C. Andree, G.M. Franssen, D.M. Roeleveld, B.M. Metselaar, T. Reinheckel, P.M. Hoogerbrugge, O.C. Boerman and F.N. van Leeuwen. "In vivo imaging of antileukemic drug asparaginase reveals a rapid macrophage mediated clearance from the bone marrow.", Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017;58(2):214-220. Abstract/PDF DOI PMID 27493268

  2. C. Smids, I.J.E. Kouijzer, F.J. Vos, T. Sprong, A.J.F. Hosman, J.W.J. de Rooy, E.H.J.G. Aarntzen, L.-F. de Geus-Oei, W.J.G. Oyen and C.P. Bleeker-Rovers. "A comparison of the diagnostic value of MRI and (18)F-FDG-PET/CT in suspected spondylodiscitis.", Infection 2017;45(1):41-49. Abstract/PDF DOI PMID 27317050

  3. S. van den Bosch, T. Dijkema, M.C. Kunze-Busch, C.H.J. Terhaard, C.P.J. Raaijmakers, P.A.H. Doornaert, F.J.P. Hoebers, M.R. Vergeer, B. Kreike, O.B. Wijers, W.J.G. Oyen and J.H.A.M. Kaanders. "Uniform FDG-PET guided GRAdient Dose prEscription to reduce late Radiation Toxicity (UPGRADE-RT): study protocol for a randomized clinical trial with dose reduction to the elective neck in head and neck squamous cell carcinoma.", BMC cancer 2017;17:208. Abstract DOI PMID 28327089

  4. B. Frigerio, G. Franssen, E. Luison, A. Satta, E. Seregni, M. Colombatti, G. Fracasso, R. Valdagni, D. Mezzanzanica, O. Boerman, S. Canevari and M. Figini. "Full preclinical validation of the 123I-labeled anti-PSMA antibody fragment ScFvD2B for prostate cancer imaging.", Oncotarget 2017;8:10919-10930. Abstract DOI PMID 28051996

  5. T. van der Geest, P. Laverman, D. Gerrits, B. Walgreen, M.M. Helsen, C. Klein, T.K. Nayak, G. Storm, J.M. Metselaar, M.I. Koenders and O.C. Boerman. "Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.", Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017;58:151-155. Abstract DOI PMID 27493266

  6. M.C.H. Hekman, O.C. Boerman, D.L. Bos, L.F.A.G. Massuger, S. Weil, L. Grasso, K.A. Rybinski, E. Oosterwijk, P.F.A. Mulders and M. Rijpkema. "Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.", Molecular pharmaceutics 2017;14:3457-3463. Abstract DOI PMID 28826214

  7. M.C.H. Hekman, M. Rijpkema, D.L. Bos, E. Oosterwijk, D.M. Goldenberg, P.F.A. Mulders and O.C. Boerman. "Detection of Micrometastases Using SPECT/Fluorescence Dual-Modality Imaging in a CEA-Expressing Tumor Model.", Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017;58:706-710. Abstract DOI PMID 28126888

  8. S. Heskamp, R. Hernandez, J.D.M. Molkenboer-Kuenen, M. Essler, F. Bruchertseifer, A. Morgenstern, E.J. Steenbergen, W. Cai, C. Seidl, W.J. McBride, D.M. Goldenberg and O.C. Boerman. "α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen-Expressing Human Colon Cancer Xenografts.", Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017;58:926-933. Abstract DOI PMID 28232604

  9. S. Heskamp, R. Raavé, O. Boerman, M. Rijpkema, V. Goncalves and F. Denat. "(89)Zr-Immuno-Positron Emission Tomography in Oncology: State-of-the-Art (89)Zr Radiochemistry.", Bioconjugate chemistry 2017;28:2211-2223. Abstract DOI PMID 28767228

  10. I. Hristova, R. Boellaard, P. Galette, L.K. Shankar, Y. Liu, S. Stroobants, O.S. Hoekstra and W.J.G. Oyen. "Guidelines for quality control of PET/CT scans in a multicenter clinical study.", EJNMMI physics 2017;4:23. Abstract DOI PMID 28924696

  11. L. Joosten, M. Brom, M.K.H. Schäfer, O.C. Boerman, E. Weihe and M. Gotthardt. "Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan.", Scientific reports 2017;7:1751. Abstract DOI PMID 28496188

  12. I.J. Kouijzer, F.J. Vos, C.P. Bleeker-Rovers and W.J. Oyen. "Clinical application of FDG-PET/CT in metastatic infections.", The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of... 2017;61:232-246. Abstract DOI PMID 26883515

  13. L.T. van der Meer, S.Y.A. Terry, D.S. van Ingen Schenau, K.C. Andree, G.M. Franssen, D.M. Roeleveld, J.M. Metselaar, T. Reinheckel, P.M. Hoogerbrugge, O.C. Boerman and F.N. van Leeuwen. "In Vivo Imaging of Antileukemic Drug Asparaginase Reveals a Rapid Macrophage-Mediated Clearance from the Bone Marrow.", Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017;58:214-220. Abstract DOI PMID 27493268

  14. T.W.H. Meijer, L.-F. de Geus-Oei, E.P. Visser, W.J.G. Oyen, M.G. Looijen-Salamon, D. Visvikis, A.F.T.M. Verhagen, J. Bussink and D. Vriens. "Tumor Delineation and Quantitative Assessment of Glucose Metabolic Rate within Histologic Subtypes of Non-Small Cell Lung Cancer by Using Dynamic (18)F Fluorodeoxyglucose PET.", Radiology 2017;283:547-559. Abstract DOI PMID 27846378

  15. V. Ruhlmann, T.D. Poeppel, J. Veit, J. Nagarajah, L. Umutlu, T.K. Hoffmann, A. Bockisch, K. Herrmann and W. Sauerwein. "Diagnostic accuracy of , javax.xml.bind.JAXBElement@1bc32ff0, F-FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma.", BMC cancer 2017;17:887. Abstract DOI PMID 29273015

  16. E.A. Usmanij, T. Natroshvili, J.N.H. Timmer-Bonte, W.J.G. Oyen, M.A. van der Drift, J. Bussink and L.-F. d. Geus-Oei. "The Predictive Value of Early In-Treatment (18)F-FDG PET/CT Response to Chemotherapy in Combination with Bevacizumab in Advanced Nonsquamous Non-Small Cell Lung Cancer.", Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2017;58:1243-1248. Abstract DOI PMID 28336778

  17. R. Wijsman, F. Dankers, E.G.C. Troost, A.L. Hoffmann, E.H.F.M. van der Heijden, L.-F. de Geus-Oei and J. Bussink. "Comparison of toxicity and outcome in advanced stage non-small cell lung cancer patients treated with intensity-modulated (chemo-)radiotherapy using IMRT or VMAT.", Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2017;122:295-299. Abstract DOI PMID 27914680

  18. S.M.A. Willekens, I. van der Kroon, D. Bos, L. Joosten, C. Frielink, O.C. Boerman, M. Brom and M. Gotthardt. "Quantitative and longitudinal imaging of intramuscular transplanted islets of Langerhans with SPECT using [ (123) I]IBZM.", Diabetes, obesity & metabolism 2017;19:604-608. Abstract DOI PMID 27987245


  1. L.K. van Dijk, C.-B. Yim, G.M. Franssen, J.H.A.M. Kaanders, J. Rajander, O. Solin, T.J. Gröroos, O.C. Boerman and J. Bussink. "PET of EGFR with (64) Cu-cetuximab-F(ab')2 in mice with head and neck squamous cell carcinoma xenografts.", Contrast media & molecular imaging 2016;11:65-70. Abstract/PDF DOI PMID 26242487

  2. I. van der Kroon, K. Andralojc, S.M.A. Willekens, D. Bos, L. Joosten, O.C. Boerman, M. Brom and M. Gotthardt. "Noninvasive Imaging of Islet Transplants with 111In-Exendin-3 SPECT/CT.", Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016;57:799-804. Abstract/PDF DOI PMID 26795287

  3. C.H.J. Muselaers, M.J. Boers-Sonderen, T.J. van Oostenbrugge, O.C. Boerman, I.M.E. Desar, A.B. Stillebroer, S.F. Mulder, C.M.L. van Herpen, J.F. Langenhuijsen, E. Oosterwijk, W.J.G. Oyen and P.F.A. Mulders. "Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.", European urology 2016;69:767-770. Abstract/PDF DOI PMID 26706103

  4. S.Y.A. Terry, M.I. Koenders, G.M. Franssen, T.K. Nayak, A. Freimoser-Grundschober, C. Klein, W.J. Oyen, O.C. Boerman and P. Laverman. "Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin ?v?3.", Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2016;57:467-472. Abstract/PDF DOI PMID 26635344

  5. W. Woliner-van der Weg, L.N. Deden, A.P.W. Meeuwis, M. Koenrades, L.H.C. Peeters, H. Kuipers, G.J. Laanstra, M. Gotthardt, C.H. Slump and E.P. Visser. "A 3D-printed anatomical pancreas and kidney phantom for optimizing SPECT/CT reconstruction settings in beta cell imaging using (111)In-exendin.", EJNMMI physics 2016;3:29. Abstract DOI PMID 27928774

  6. R. Bertrand, A. Wolf, Y. Ivashchenko, M. Löhn, M. Schäfer, M. Brönstrup, M. Gotthardt, V. Derdau and O. Plettenburg. "Synthesis and Characterization of a Promising Novel FFAR1/GPR40 Targeting Fluorescent Probe for ?-Cell Imaging.", ACS chemical biology 2016;11:1745-1754. Abstract DOI PMID 27115176

  7. I. van der Kroon, L. Joosten, B.A. Nock, T. Maina, O.C. Boerman, M. Brom and M. Gotthardt. "Improved Quantification of the Beta Cell Mass after Pancreas Visualization with (99m)Tc-demobesin-4 and Beta Cell Imaging with (111)In-exendin-3 in Rodents.", Molecular pharmaceutics 2016;13:3478-3483. Abstract PMID 27537699

  8. A.I.J. Arens, J.W.A. Postema, W.M.J. Schreurs, A. Lafeber, B.W. Hendrickx, W.J.G. Oyen and W.V. Vogel. "FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer.", PloS one 2016;11:e0160539. Abstract DOI PMID 27556809

  9. D.L. Bailey, B.J. Pichler, B. Gückel, H. Barthel, A.J. Beer, R. Botnar, R. Gillies, V. Goh, M. Gotthardt, R.J. Hicks, R. Lanzenberger, C. la Fougere, M. Lentschig, S.G. Nekolla, T. Niederdraenk, K. Nikolaou, J. Nuyts, D. Olego, K. Riklund, A. Signore, M. Schäfers, V. Sossi, M. Suminski, P. Veit-Haibach, L. Umutlu, M. Wissmeyer and T. Beyer. "Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany", Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2016;18:637-650. Abstract DOI PMID 27534971

  10. M. Brom, G.M. Franssen, L. Joosten, M. Gotthardt and O.C. Boerman. "The effect of purification of Ga-68-labeled exendin on in vivo distribution.", EJNMMI research 2016;6:65. Abstract DOI PMID 27518873

  11. T.J.A. Hutten, S. Thordardottir, H. Fredrix, L. Janssen, R. Woestenenk, J. Tel, B. Joosten, A. Cambi, M.H.M. Heemskerk, G.M. Franssen, O.C. Boerman, L.B.H. Bakker, J.H. Jansen, N. Schaap, H. Dolstra and W. Hobo. "CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.", Journal of immunology (Baltimore, Md. : 1950) 2016. Abstract PMID 27566820

  12. T. van der Geest, P. Laverman, J.M. Metselaar, G. Storm and O.C. Boerman. "Radionuclide imaging of liposomal drug delivery.", Expert Opin Drug Deliv 2016;13(9):1231-1242. Abstract DOI PMID 27351233

  13. R.A. Valdes Olmos, L.-F. de Geus-Oei, C.H.J.M. Ticheler and J.L. Bloem. "From Incidentaloma to Oncocytoma: A Role for Hybrid Molecular Imaging in Characterising Renal Masses?", Eur Urol 2016;69(3):417-418. DOI PMID 26453374

  14. R. de Bree, L. van der Putten, H. van Tinteren, J. Wedman, W.J.G. Oyen, L.M. Janssen, M.W.M. van den Brekel, E.F.I. Comans, J. Pruim, R.P. Takes, M.G.G. Hobbelink, R. Valdes Olmos, B.F.A.M. van der Laan, M. Boers, O.S. Hoekstra and C.R. Leemans. "Effectiveness of an (18)F-FDG-PET based strategy to optimize the diagnostic trajectory of suspected recurrent laryngeal carcinoma after radiotherapy: The RELAPS multicenter randomized trial.", Radiother Oncol 2016;118(2):251-256. Abstract DOI PMID 26477395

  15. R. Bertrand, I. Hamp, M. Brönstrup, R. Weck, M. Lukacevic, A. Polyak, T.L. Ross, M. Gotthardt, O. Plettenburg and V. Derdau. "Synthesis of GPR40 targeting (3) H- and (18) F-probes towards selective beta cell imaging.", J Labelled Comp Radiopharm 2016;59(14):604-610. Abstract/PDF DOI PMID 27282912

  16. W. Grootjans, F. Tixier, C.S. van der Vos, D. Vriens, C.C. Le Rest, J. Bussink, W.J.G. Oyen, L.-F. de Geus-Oei, D. Visvikis and E.P. Visser. "The impact of optimal respiratory gating and image noise on evaluation of intra-tumor heterogeneity in 18F-FDG positron emission tomography imaging of lung cancer.", J Nucl Med 2016;57(11):1692-1698. Abstract/PDF DOI PMID 27283931

  17. K.L.S. Chatalic, S. Heskamp, M. Konijnenberg, J.D.M. Molkenboer-Kuenen, G.M. Franssen, M.C. Clahsen-van Groningen, M. Schottelius, H.-Jü. Wester, W.M. van Weerden, O.C. Boerman and M. de Jong. "Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent.", Theranostics 2016;6(6):849-861. Abstract DOI PMID 27162555

  18. W. Grootjans, E.A. Usmanij, W.J.G. Oyen, E.H.F.M. van der Heijden, E.P. Visser, D. Visvikis, M. Hatt, J. Bussink and L.-F. de Geus-Oei. "Performance of automatic image segmentation algorithms for calculating total lesion glycolysis for early response monitoring in non-small cell lung cancer patients during concomitant chemoradiotherapy.", Radiother Oncol 2016. Abstract DOI PMID 27178141

  19. T. Puar, A. van Berkel, M. Gotthardt, B. Havekes, A.R.M.M. Hermus, J.W.M. Lenders, W.D. van Marken Lichtenbelt, Y. Xu, B. Brans and H.J.L.M. Timmers. "Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.", J Clin Endocrinol Metab 2016;101(1):224-232. Abstract DOI PMID 26574955

  20. E.H.J.G. Aarntzen, R. Hermsen, J.P.H. Drenth, O.C. Boerman and W.J.G. Oyen. "99mTc-CXCL8 SPECT to Monitor Disease Activity in Inflammatory Bowel Disease.", J Nucl Med 2016;57(3):398-403. Abstract DOI PMID 26609182

  21. S.M.A. Willekens, I. van der Kroon, L. Joosten, C. Frielink, O.C. Boerman, S.A.M.W. van den Broek, M. Brom and M. Gotthardt. "SPECT of Transplanted Islets of Langerhans by Dopamine 2 Receptor Targeting in a Rat Model.", Mol Pharm 2016;13(1):85-91. Abstract DOI PMID 26607139

  22. W.A. Eter, S. Parween, L. Joosten, C. Frielink, M. Eriksson, M. Brom, U. Ahlgren and M. Gotthardt. "SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for β-cell mass assessments.", Scientific reports 2016;6:24576. Abstract DOI PMID 27080529


  1. G. Gebhart, L.E. Lamberts, Z. Wimana, C. Garcia, P. Emonts, L. Ameye, S. Stroobants, M. Huizing, P. Aftimos, J. Tol, W.J.G. Oyen, D.J. Vugts, O.S. Hoekstra, C.P. Schröder, C.W. Menke-van der Houven van Oordt, T. Guiot, A.H. Brouwers, A. Awada, E.G.E. de Vries and P. Flamen. "Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial.", Annals of oncology : official journal of the European Society for Medical Oncology 2015;27:619-624. Abstract DOI PMID 26598545

  2. S. Lütje, S. Heskamp, A.S. Cornelissen, T.D. Poeppel, S.A. van den Broek, S. Rosenbaum-Krumme, A. Bockisch, M. Gotthardt, M. Rijpkema and O.C. Boerman. "PSMA Ligands for Radionuclide Imaging and Therapy of Prostate Cancer: Clinical Status", Theranostics 2015;5(12):1388.


  1. K. Aben, S. Heskamp, M. Janssen-Heijnen, E. Koldewijn, C. van Herpen, L. Kiemeney, E. Oosterwijk and D.J. van Spronsen. "Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the Netherlands", European Journal of Cancer 2011;47(13):2023-2032.